Gu, Namyi
65  Ergebnisse:
Personensuche X
?
1

Determination of candesartan or olmesartan in hypertensive ..:

Jeong, Hyeon-Cheol ; Seo, Yo-Han ; Gu, Namyi..
Translational and Clinical Pharmacology.  29 (2021)  4 - p. 226 , 2021
 
?
2

Prevalence and characteristics of isolated nocturnal hypert..:

Rhee, Moo-Yong ; Kim, Je Sang ; Kim, Chee Hae...
The Korean Journal of Internal Medicine.  36 (2021)  5 - p. 1126-1133 , 2021
 
?
3

Prospective observational study of the impact of plasma col..:

Jeong, Yun-Jeong ; Gu, Namyi ; Kwack, Won Gun...
Journal of Global Antimicrobial Resistance.  27 (2021)  - p. 315-323 , 2021
 
?
 
?
6

Possibility of pharmacokinetic drug interaction between a D..:

Gu, Namyi ; Park, Sang-In ; Chung, Hyewon...
Translational and Clinical Pharmacology.  28 (2020)  1 - p. 17 , 2020
 
?
7

Difference in 24‐hour urine sodium excretion between contro..:

Rhee, Moo‐Yong ; Jo, Sang‐Ho ; Kim, Ji‐Hyun...
The Journal of Clinical Hypertension.  21 (2019)  8 - p. 1057-1062 , 2019
 
?
9

Dose–response association of 24-hour urine sodium and sodiu..:

Kyung Kim, Mi ; Kwon, Minji ; Rhee, Moo-Yong...
European Journal of Preventive Cardiology.  26 (2019)  9 - p. 952-960 , 2019
 
?
 
?
11

Survey on the undergraduate curriculum in clinical pharmaco..:

Gu, Namyi ; Kim, Kyong-Jee ; Lim, Chi-Yeon...
Translational and Clinical Pharmacology.  26 (2018)  3 - p. 128 , 2018
 
?
 
?
14

A first-in-human, double-blind, placebo-controlled, randomi..:

Lee, Jieon ; Kim, Bo-Hyung ; Yu, Kyung-Sang...
Drug Design, Development and Therapy.  11 (2017)  - p. 1301-1313 , 2017
 
?
15

The Effect of Genetic Polymorphisms inSLCO2B1on the Lipid-L..:

Kim, Tae-Eun ; Shin, Dongseong ; Gu, Namyi...
Basic & Clinical Pharmacology & Toxicology.  121 (2017)  3 - p. 195-201 , 2017
 
1-15